Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-05-26 Purchase | 2023-05-26 2:53 pm | AbCellera Biologics Inc. | ABCL | Booth Andrew Chief Financial Officer | 14,500 | $6.85 | $99,325 | 283,959 (Indirect Direct) | View |
| 2022-05-12 Purchase | 2022-05-16 2:13 pm | AbCellera Biologics Inc. | ABCL | Booth Andrew Chief Financial Officer | 85,000 | $5.79 | $492,150 | 269,459 (Indirect Direct) | View |
| 2021-11-11 Purchase | 2021-11-15 06:05 am | AbCellera Biologics Inc. | ABCL | Booth Andrew Chief Financial Officer | 67,500 | $14.71 | $993,130 | 184,459 (Indirect Direct) | View |
| 2021-06-09 Sale | 2021-06-10 5:00 pm | AbCellera Biologics Inc. | ABCL | Booth Andrew Chief Financial Officer | 1,200,000 | $25.5 | $30,600,000 | 116,959 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-01-14 Option Award | 2024-01-16 6:18 pm | N/A 2034-01-14 | AbCellera Biologics Inc. | ABCL | Booth Andrew Chief Financial Officer | 770,416 | $0 | 6,590,897 (Direct) | View |
| 2022-12-20 Gift | 2022-12-22 2:31 pm | N/A N/A | AbCellera Biologics Inc. | ABCL | Booth Andrew Chief Financial Officer | 50,000 | $0 | 6,089,940 (Direct) | View |
| 2022-12-20 Exercise | 2022-12-22 2:31 pm | N/A 2026-06-15 | AbCellera Biologics Inc. | ABCL | Booth Andrew Chief Financial Officer | 50,000 | $0 | 6,089,940 (Direct) | View |
| 2022-12-20 Exercise | 2022-12-22 2:31 pm | N/A N/A | AbCellera Biologics Inc. | ABCL | Booth Andrew Chief Financial Officer | 50,000 | $0.19 | 6,089,940 (Direct) | View |
| 2022-12-01 Option Award | 2022-12-05 12:19 pm | N/A 2032-12-01 | AbCellera Biologics Inc. | ABCL | Booth Andrew Chief Financial Officer | 485,661 | $0 | 5,870,481 (Direct) | View |
| 2021-12-10 Ownership | 2022-02-03 6:54 pm | N/A N/A | AbCellera Biologics Inc. | ABCL | Booth Andrew Chief Financial Officer | 500,000 | $0 | 184,459 (Direct) | View |
Ownership | 2022-02-03 6:54 pm | N/A N/A | AbCellera Biologics Inc. | ABCL | Booth Andrew Chief Financial Officer | 0 | $0 | 184,459 (Indirect) | View |
| 2021-12-10 Exercise | 2021-12-10 5:00 pm | N/A N/A | AbCellera Biologics Inc. | ABCL | Booth Andrew Chief Financial Officer | 500,000 | $0.32 | 6,069,279 (Direct) | View |
| 2021-12-10 Exercise | 2021-12-10 5:00 pm | 2020-03-23 2029-08-22 | AbCellera Biologics Inc. | ABCL | Booth Andrew Chief Financial Officer | 500,000 | $0 | 6,069,279 (Direct) | View |
| 2021-12-07 Option Award | 2021-12-09 5:58 pm | N/A 2031-12-07 | AbCellera Biologics Inc. | ABCL | Booth Andrew Chief Financial Officer | 406,020 | $0 | 6,069,279 (Direct) | View |
| 2021-06-07 Exercise | 2021-06-09 8:30 pm | N/A N/A | AbCellera Biologics Inc. | ABCL | Booth Andrew Chief Financial Officer | 600,000 | $0.32 | 6,566,959 (Direct) | View |
| 2021-06-07 Exercise | 2021-06-09 8:30 pm | N/A 2026-06-15 | AbCellera Biologics Inc. | ABCL | Booth Andrew Chief Financial Officer | 1,200,000 | $0 | 6,566,959 (Direct) | View |
| 2021-06-07 Exercise | 2021-06-09 8:30 pm | N/A N/A | AbCellera Biologics Inc. | ABCL | Booth Andrew Chief Financial Officer | 600,000 | $0.19 | 6,566,959 (Direct) | View |
Ownership | 2020-12-11 8:00 pm | N/A N/A | AbCellera Biologics Inc. | ABCL | Booth Andrew Chief Financial Officer | 0 | $0 | 6,795,759 (Indirect) | View |